In our first of our Transforming Cardiac Care webinar series, our panelists discussed a highly promising, clinically proven new standard of heart care and AI-driven digital technology that allows physicians to more accurately measure disease, guide treatment, and prevent future heart attacks.
Founder and CEO, Cleerly Inc.
Dr. Min is a world recognized authority on cardiovascular imaging and physician scientist who understands the inter-relationships between non-invasive imaging, coronary angiography and revascularization.
CMO, Cleerly Inc.
Dr. Earls is a Professor of Radiology at George Washington University Hospital and a leader within the field of Radiology in applications of advanced imaging technologies in cardiovascular care.
Assistant Professor of Cardiovascular Disease, University of Milan
Dr. Andreini is a leading cardiologist who is changing the way the industry approaches diagnosis and risk prediction of heart disease using non-invasive coronary computed tomography angiography.
High-risk atherosclerosis is the strongest predictor of future heart attack risk. Our discussion included three areas critical to a new approach:
Traditional methods of heart disease evaluation and risk stratification are failing too many patients.
Critical differences in plaque types and how they can be changed and tracked with CCTA enabled by artificial intelligence (AI).
Why atherosclerosis — the strongest predictor of heart attack risk — is all that matters.
The Cleerly webinars are open to any cardiologist, radiologist or other healthcare professional with an interest in breakthrough medtech for heart disease and prevention. Watch Webinar